MedPath

Stempeutics Research Pvt. Ltd.

Stempeutics Research Pvt. Ltd. logo
🇮🇳India
Ownership
Private
Established
2006-01-01
Employees
51
Market Cap
-
Website
http://www.stempeutics.com

Clinical Trials

42

Active:0
Completed:22

Trial Phases

5 Phases

Phase 1:13
Phase 2:13
Phase 3:8
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (40 trials with phase data)• Click on a phase to view related trials

Phase 1
13 (32.5%)
Phase 2
13 (32.5%)
Phase 3
8 (20.0%)
Not Applicable
3 (7.5%)
phase_1_2
2 (5.0%)
Phase 4
1 (2.5%)

A Clinical Trial to Study the Efficacy and Safety of Stempeucel® in Patients With CLI Due to Buergers Disease

Phase 2
Withdrawn
Conditions
Critical Limb Ischemia Due to Buerger's Disease
First Posted Date
2017-02-17
Last Posted Date
2017-04-07
Lead Sponsor
Stempeutics Research Pvt Ltd
Registration Number
NCT03056742
Locations
🇮🇳

Department of Surgical Disciplines, All India Institute of Medical Sciences, New Delhi, Delhi, India

🇮🇳

Department of Vascular and Endovascular Surgery, M. S. Ramaiah Medical College and Hospitals, Bangalore, Karnataka, India

🇮🇳

Department of Vascular Surgery, Madras Medical College, Chennai, Tamil Nadu, India

and more 5 locations

Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis

Phase 2
Completed
Conditions
Alcoholic Liver Cirrhosis
First Posted Date
2012-05-03
Last Posted Date
2016-09-15
Lead Sponsor
Stempeutics Research Pvt Ltd
Target Recruit Count
40
Registration Number
NCT01591200
Locations
🇮🇳

Centre for Liver Research & Diagnostics, Hyderabad, Andhra Pradesh, India

🇮🇳

Mediciti Hospital, Hyderabad, Andhra Pradesh, India

🇮🇳

Manipal Hospital, Bangalore, Karnataka, India

and more 7 locations

A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease

Phase 2
Completed
Conditions
Buerger's Disease
Critical Limb Ischemia
First Posted Date
2011-12-02
Last Posted Date
2016-09-13
Lead Sponsor
Stempeutics Research Pvt Ltd
Target Recruit Count
90
Registration Number
NCT01484574
Locations
🇮🇳

Department of Surgical Disciplines, All India Institute of Medical Sciences, New Delhi, Delhi, India

🇮🇳

Division of Peripheral Vascular and Endovascular Sciences, Medanta - The Medicity, Gurgaon, Haryana, India

🇮🇳

Department of Vascular and Endovascular Surgery, M. S. Ramaiah Medical College and Hospitals, Bangalore, Karnataka, India

and more 7 locations

Allogeneic Mesenchymal Stem Cells in Osteoarthritis

Phase 2
Completed
Conditions
Osteoarthritis of Knee
First Posted Date
2011-10-18
Last Posted Date
2016-05-12
Lead Sponsor
Stempeutics Research Pvt Ltd
Target Recruit Count
60
Registration Number
NCT01453738
Locations
🇮🇳

Department of Orthopedics, M. S. Ramaiah Memorial Hospital, Bangalore, Karnataka, India

🇮🇳

Department of Orthopedics, Kasturba Medical College, Manipal, Karnataka, India

🇮🇳

Seth G. S. Medical College and KEM Hospital, Mumbai, Maharashtra, India

and more 2 locations

Allogeneic Mesenchymal Stem Cells for Osteoarthritis

Phase 2
Completed
Conditions
Osteoarthritis of Knee Joint
First Posted Date
2011-10-07
Last Posted Date
2016-05-12
Lead Sponsor
Stempeutics Research Pvt Ltd
Target Recruit Count
72
Registration Number
NCT01448434
Locations
🇲🇾

Pantai Cheras Medical Centre, Kuala Lumpur, Federal territory, Malaysia

🇲🇾

Serdang Hospital, Kuala Lumpur, Selangor, Malaysia

🇲🇾

KPJ Ampang Puteri Specialist Hospital, Kuala Lumpur, Selangor, Malaysia

and more 1 locations
  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.